NCT04768283

Brief Summary

The aim of this study is to evaluate functional and physical capacity, health-related quality of life and associations with frailty in older patients after ischemic heart disease and interventional treatment with an individualized physical training program in the second phase of cardiac rehabilitation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 6, 2020

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 21, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 24, 2021

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2022

Completed
Last Updated

March 4, 2021

Status Verified

March 1, 2021

Enrollment Period

2.8 years

First QC Date

February 21, 2021

Last Update Submit

March 2, 2021

Conditions

Keywords

FrailtyCardiac surgeryCardiac rehabilitationExercise trainingResistance trainingBalance training

Outcome Measures

Primary Outcomes (5)

  • Frailty level by Edmonton frail scale score

    Frailty measured by The Edmonton frail scale score - 0-3 - fit, 4-5 - vulnerable, 6-7 - mild frailty, 8-9 - moderate frailty,10-17 - severe frailty.

    baseline

  • Change from baseline functional capacity by six minutes walking test (6MWT)

    6MWT measured by meters

    baseline, 3 weeks

  • Change from baseline cardiopulmonary exercise capacity by maximal load (maxWatt)

    Maximal load measured with spiroergometry by maximal watts

    baseline, 3 weeks

  • Change from baseline cardiopulmonary exercise capacity by maximal oxygen consumption (peakVO2)

    PeakVO2 measured with spiroergometry by millilitres of oxygen per kilogram of body mass per minute

    baseline, 3 weeks

  • Change from baseline quality of life by MacNew questionnaire

    The MacNew Heart Disease HRQL questionnaire consists of 27 items which fall into three domains (a 13-item physical limitations domain scale, a 14-item emotional function domain scale, and a 13-item social function domain scale). There are 5 items that inquire about symptoms: angina/chest pain, shortness of breath, fatigue, dizziness, and aching legs. The time frame for the MacNew is the previous two weeks.

    baseline, 3 weeks

Secondary Outcomes (2)

  • Change from baseline physical performance by Short Physical Performance Battery (SPPB)

    baseline, 3 weeks

  • Change from baseline muscular strength by one repetition maximum test (1RM)

    baseline, 3 weeks

Study Arms (3)

Control group

NO INTERVENTION

Cardiac rehabilitation physical training program included: respiratory muscle training (7 days/week, for 15 minutes) and aerobic exercises on cycle ergometers (6 days/week, for 10-30 minutes, 30-50% watts or 30-50% HRmax).

Intervention group 1

EXPERIMENTAL

Combinated physical training program: Respiratory exercises, aerobic training will be the same as in the control group. Additional exercises: balance training and strength exercises with weights, elastic resistance rubbers.

Other: Additional balance and resistance training - 1

Intervention group 2

EXPERIMENTAL

Combinated physical training program: Respiratory exercises, aerobic training will be the same as in the control group. Additional exercises: balance training with static and dynamic balance training device Biodex Balance System TM SD and strength exercises with HUR strength training machines.

Other: Additional balance and resistance training - 2

Interventions

Additional exercise program with balance and resistance training three times per week. The balance training included exercises to improve static as well as dynamic balance ability, for 15-20 minutes. The resistance training included exercises with weights (0,5, 1 or 2 kg), elastic resistance rubbers, intensity 30-50% 1-RM, 10 repetitions with 3 sets and 3 minute rest between sets.

Intervention group 1

Additional exercise program with balance and resistance training three times per week. The balance training included exercises with static and dynamic balance training device Biodex Balance System TM SD, for 15-20 minutes. Exercises are performed with the following programs: Postural stability training, Limits of stability training, Weight shift training, Maze control training, Random control training, Percent weight-bearing training. The resistance training included exercises with HUR strength training machines, intensity 30-50% 1-RM, 10 repetitions with 3 sets and 3 minute rest between sets. Strength training was performed with the following exercises: Leg press, leg extension, leg abduction, leg adduction.

Intervention group 2

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Patients after acute coronary syndrome and percutaneous coronary intervention or coronary bypass surgery;
  • Age 65 years and older;
  • minute walk distance (6-MWD) ≥150 meters;
  • Left ventricular ejection fraction ≥ 40%;
  • Patient's agreement to participate in the study.

You may not qualify if:

  • combined coronary artery bypass grafting and valve surgery;
  • Cardiac devices;
  • Diseases in the musculoskeletal system or other organs complicating physical activity and exercise training;
  • Exercise-limiting comorbidities (primarily orthopedic and neurological conditions that would exclude individuals from participating in cardiac rehabilitation according to study protocol), cognitive or linguistic deficits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

LUHS hospital Kaunas Clinics Rehabilitation hospital of Kulautuva

Kulautuva, Kaunas County, Lithuania

RECRUITING

MeSH Terms

Conditions

FrailtyCoronary Artery Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsCoronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Aurelija Beigienė, MD

Study Record Dates

First Submitted

February 21, 2021

First Posted

February 24, 2021

Study Start

January 6, 2020

Primary Completion

October 30, 2022

Study Completion

October 30, 2022

Last Updated

March 4, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations